title: Subcutaneous allergen specific immunotherapy: best clinical practice as cornerstone for future development.
abstract: Allergen subcutaneous immunotherapy is a long lasting treatment which can modify the natural history of allergic respiratory diseases. Recommended administration is required for a minimum of three years. During this long term therapy the daily management is based on two crucial points, discussed in this review, such as the prevention and the treatment of side effects and the improvement and follow-up of patient adherence. This review specifically focuses on subcutaneous immunotherapy.
authors.affiliation: Allergy Unit, Verona General Hospital, Italy. gianenrico.senna@ospedaleuniverona.it
authors.forename: G E
authors.initials: GE
authors.lastname: Senna
authors.forename: M
authors.initials: M
authors.lastname: Makatsori
authors.forename: M
authors.initials: M
authors.lastname: Schiappoli
authors.forename: A R
authors.initials: AR
authors.lastname: Dama
mesh_terms: D003888:Desensitization, Immunologic / Q000379:methods / Q000639:trends; D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control; D006801:Humans; D007279:Injections, Subcutaneous; D010349:Patient Compliance; D017410:Practice Guidelines as Topic; D012130:Respiratory Hypersensitivity / Q000188:drug therapy* / Q000276:immunology; D013997:Time Factors